Jose has 10 years’ experience in antibody discovery and preclinical development in biotech and pharma. He was previously at F-star Therapeutics where he led immune cell engager programmes from inception to pre-IND, and beyond into Phase I, spanning multiple internal and external drug candidates, publications, and patents. He also held key platform, technology, and pharmacology development roles within F-star. Before joining Adaptate, Jose also held other scientific roles within AstraZeneca and Cambridge Antibody Technology.
Jose holds a PhD in Molecular Biology from the University of Barcelona.